Last reviewed · How we verify
hematin
hematin is a hematin drug. It is currently in unknown development for Iron deficiency anemia, Megaloblastic anemia due to folate deficiency.
Hematin works by replenishing iron stores in the body, which is essential for the production of red blood cells.
Hematin is a dark bluish or brownish pigment containing iron in the ferric state, obtained by the oxidation of haem. It is a small molecule used in clinical studies for the treatment of Acute Promyelocytic Leukemia, often in combination with other interventions such as ATRA.
At a glance
| Generic name | hematin |
|---|---|
| Drug class | hematin |
| Therapeutic area | Hematology |
| Phase | unknown |
Mechanism of action
Think of hematin like a refill for your body's iron tank. When you're low on iron, your body can't make enough healthy red blood cells, leading to anemia. Hematin helps fill the tank, allowing your body to produce the red blood cells it needs to function properly.
Approved indications
- Iron deficiency anemia
- Megaloblastic anemia due to folate deficiency
Common side effects
Key clinical trials
- Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies (PHASE2)
- Recombinant Human Serum Albumin in the Treatment of AD (Alzheimer Disease) Exploratory Clinical Trials (EARLY_PHASE1)
- Recombinant Human Serum Albumin in Healthy Subjects (PHASE1)
- Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects (PHASE1)
- Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites (PHASE2,PHASE3)
- Phase II/III of Recombinant Human Serum Albumin (PHASE2,PHASE3)
- 5-AminoLevulinic Acid Aided Resection Margins in Sarcoma (EARLY_PHASE1)
- MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- hematin CI brief — competitive landscape report
- hematin updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about hematin
What is hematin?
How does hematin work?
What is hematin used for?
What drug class is hematin in?
What development phase is hematin in?
Related
- Drug class: All hematin drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Hematology
- Indication: Drugs for Iron deficiency anemia
- Indication: Drugs for Megaloblastic anemia due to folate deficiency
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing